Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
19 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
INNOVATIVE MICROBIAL BIOPROCESS from Anderlecht, company number BE0477640767, closed financial year 2025 with a result of € 8,023 after tax. For that financial year INNOVATIVE MICROBIAL BIOPROCESS recorded a gross margin of € 12,165 and equity of € 131,142. Compared with financial year 2024, the result moved from € 6,802 to € 8,023. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.
€ 131,142
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 8,023
▲ 18% vs 2024
Profit after tax over the fiscal year.
€ 74,453
▼ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 69,122.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 117
▲ 132% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 9,960 | € 12,468 | € 9,848 | € 12,165 | ▲ 24% |
| Profit after taxes | € 7,283 | € 8,563 | € 6,802 | € 8,023 | ▲ 18% |
| Equity | € 125,473 | € 134,037 | € 123,119 | € 131,142 | ▲ 7% |
| Total debts | € 2,099 | € 689 | € 20,143 | € 166 | ▼ 99% |
| Cash | € 40,963 | € 46,170 | € 80,336 | € 74,453 | ▼ 7% |
| Retained profit | € 63,453 | € 72,017 | € 61,099 | € 69,122 | ▲ 13% |
| Dividend | € 0 | € 0 | € 17,720 | € 0 | ▼ 100% |
| Balance sheet total | € 127,572 | € 134,726 | € 143,262 | € 131,307 | ▼ 8% |
Key figures of INNOVATIVE MICROBIAL BIOPROCESS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INNOVATIVE MICROBIAL BIOPROCESS?
What happened at INNOVATIVE MICROBIAL BIOPROCESS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Ruben WERQUIN stepped down as director. NBB
- Catherine SAINT-HUBERT stepped down as director. NBB
- Laurence VAN NEDERVELDE stepped down as director. NBB
- Stéphane VERSTRAETE stepped down as director. NBB
- AQUATIC SCIENCE SA stepped down as director. NBB
- Alain DURIEUX stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 8,023 (▲ 18% vs 2024). Source: NBB ↗
- Ruben WERQUIN became a director. NBB
In short
From € 7,283 profit in 2022 to € 8,023 profit in 2025.
Paid € 10,729 in corporate taxes since 2022.
Best year ever: 2023, with € 8,563 profit.
Paid out € 17,720 in dividends to the owners in total.
A new publication or filing at INNOVATIVE MICROBIAL BIOPROCESS? We notify you, reason included.
Follow INNOVATIVE MICROBIAL BIOPROCESSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of AQUATIC SCIENCE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
INNOVATIVE MICROBIAL BIOPROCESSThe shares are held by AQUATIC SCIENCE (19.9%).
Directors
According to the 2025 annual accounts
Catherine SAINT-HUBERT
Director
Also active at: MEURICE RECHERCHE ET DEVELOPPEMENT - MEURICE RESEARCH AND DEVELOPMENT
since 2020 · until 2026
Laurence VAN NEDERVELDE
Director
Also active at: MEURICE RECHERCHE ET DEVELOPPEMENT - MEURICE RESEARCH AND DEVELOPMENT
since 2020 · until 2026
Ruben WERQUIN
Director
since 2024 · until 2030
Stéphane VERSTRAETE
Director
since 2020 · until 2026
since 2020 · until 2026
Alain DURIEUX
Managing director
Also active at: EEBIC, MEURICE RECHERCHE ET DEVELOPPEMENT - MEURICE RESEARCH AND DEVELOPMENT
since 2020 · until 2026
Shareholders
19.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Emile Grysonlaan 1
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 19 companies are registered at this address.
All companies at this address →Centre d'Enseignement et de Recherche des Industries Alimentaires et Chimiques (Province de Brabant)
Association royale des Anciens Etudiants de l'Institut des Industries de Fermentation de Bruxelles(C.E.R.I.A.)
Association des Techniciens de l'Industrie des Peintures et des Industries Connexes
ASSOCIATION ROYALE DES INGÉNIEURS DIPLOMÉS DE L'INSTITUT MEURICE
Vereniging der Afgestudeerden van het Normaalinstituut voor Technisch Onderwijs
+14 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0477.640.767
- VAT number
- BE 0477.640.767
- Registered office
- Emile Grysonlaan 1, 1070 Anderlecht
- Names & denominations
- INNOVATIVE MICROBIAL BIOPROCESS · IMBP
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 2002
- Peppol
- Active · Active since 4 Jul 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied